by Truveta staff | Feb 20, 2025 | Research
Recently, researchers presented new epilepsy research at the American Epilepsy Society Annual Meeting in Los Angeles, California. Using Truveta Data, the researchers explored two important topics: the link between epilepsy, anti-seizure medications, and cardiac...
by Truveta staff | Feb 18, 2025 | Research
Influenza continues to be on the rise. Influenza-related hospitalizations increased by 53.7% and now are associated with 6.8% of all hospitalizations. For kids aged 4 and younger and adults aged 65 and older, the current rate of influenza-related hospitalizations is...
by Truveta Research | Feb 4, 2025 | Research, Research Insights
Mental health prescribing remained relatively stable since 2018. Prescription rates for antidepressants, mood stabilizers, and antipsychotics peaked between 2020 and 2022 but have since stabilized or slightly declined compared to 2018 rates. Anxiolytic prescriptions...
by Truveta staff | Jan 31, 2025 | Research
Discontinuation within one year was significantly higher in patients without T2D (64.8%) compared to those with T2D (46.5%). When patients experienced greater weight loss, they were less likely to discontinue the GLP-1 RA medications. Among patients with T2D, higher...
by Truveta staff | Jan 21, 2025 | Research
Overall, the rate of hospitalizations associated with respiratory viruses increased 3-fold between the end of November and end of December (209.2% increase). Respiratory viruses now are associated with 9.3% of all hospitalizations. Rates of influenza-associated...
by Truveta Research | Dec 21, 2024 | Research, Research Insights
In an exclusive analysis for the Wall Street Journal, Truveta Research explored mental health-related emergency department visits. The rate of ED encounters related to mental health conditions peaked in 2021 for all conditions studied, besides schizophrenia, which...
